Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1990;81:1161-1172

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pfeffer, M. A.
Right arrow Articles by Braunwald, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pfeffer, M. A.
Right arrow Articles by Braunwald, E.

Circulation, Vol 81, 1161-1172, Copyright © 1990 by American Heart Association


ARTICLES

Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications

MA Pfeffer and E Braunwald
Department of Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115.

An acute myocardial infarction, particularly one that is large and transmural, can produce alterations in the topography of both the infarcted and noninfarcted regions of the ventricle. This remodeling can importantly affect the function of the ventricle and the prognosis for survival. In the early period, infarct expansion has been recognized by echocardiography as a lengthening of the noncontractile region. The noninfarcted region also undergoes an important lengthening that is consistent with a secondary volume-overload hypertrophy and that can be progressive. The extent of ventricular enlargement after infarction is related to the magnitude of the initial damage to the myocardium and, although an increase in cavity size tends to restore stroke volume despite a persistently depressed ejection fraction, ventricular dilation has been associated with a reduction in survival. The process of ventricular enlargement can be influenced by three interdependent factors, that is, infarct size, infarct healing, and ventricular wall stresses. A most effective way to prevent or minimize the increase in ventricular size after infarction and the consequent adverse effect on prognosis is to limit the initial insult. Acute reperfusion therapy has been consistently shown to result in a reduction in ventricular volume. The reestablishment of blood flow to the infarcted region, even beyond the time frame for myocyte salvage, has beneficial effects in attenuating ventricular enlargement. The process of scarification can be interfered with during the acute infarct period by the administration of glucocorticosteroids and nonsteroidal antiinflammatory agents, which result in thinner infarcts and greater degrees of infarct expansion. Modification of distending or deforming forces can importantly influence ventricular enlargement. Even short-term augmentations in afterload have deleterious long-term effects on ventricular topography. Conversely, judicious use of nitroglycerin seems to be associated with an attenuation of infarct expansion and long-term improvement in clinical outcome. Long-term therapy with an angiotensin converting enzyme inhibitor can favorably alter the loading conditions on the left ventricle and reduce progressive ventricular enlargement as demonstrated in both experimental and clinical studies. With the former therapy, this attenuation of ventricular enlargement was associated with a prolongation in survival. The long-term clinical consequences of long- term angiotensin converting enzyme inhibitor therapy after myocardial infarction is currently being evaluated. Although studies directed at attenuating left ventricular remodeling after infarction are in the early stages, it does seem that this will be an important area in which future research might improve long-term outcome after infarction.


This article has been cited by other articles:


Home page
Eur Heart JHome page
D. Kelly, S. Q. Khan, M. Thompson, G. Cockerill, L. L. Ng, N. Samani, and I. B. Squire
Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction
Eur. Heart J., July 8, 2008; (2008) ehn315v1.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. Mulder, V. Mellin, J. Favre, M. Vercauteren, I. Remy-Jouet, C. Monteil, V. Richard, S. Renet, J. P. Henry, A. Y. Jeng, et al.
Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone
Eur. Heart J., June 27, 2008; (2008) ehn277v1.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. V. Ennezat, N. Lamblin, F. Mouquet, O. Tricot, P. Quandalle, V. Aumegeat, O. Equine, O. Nugue, B. Segrestin, P. de Groote, et al.
The effect of ageing on cardiac remodelling and hospitalization for heart failure after an inaugural anterior myocardial infarction
Eur. Heart J., June 20, 2008; (2008) ehn267v1.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
E. Braunwald
Biomarkers in Heart Failure
N. Engl. J. Med., May 15, 2008; 358(20): 2148 - 2159.
[Full Text] [PDF]


Home page
CirculationHome page
D. D. Schocken, E. J. Benjamin, G. C. Fonarow, H. M. Krumholz, D. Levy, G. A. Mensah, J. Narula, E. S. Shor, J. B. Young, and Y. Hong
Prevention of Heart Failure: A Scientific Statement From the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group
Circulation, May 13, 2008; 117(19): 2544 - 2565.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. K. Yankey, T. Li, A. Kilic, G. Cheng, A. Satpute, K. Savai, S. Li, S. L. Moainie, D. Prastein, C. DeFillipi, et al.
Regional remodeling strain and its association with myocardial apoptosis after myocardial infarction in an ovine model.
J. Thorac. Cardiovasc. Surg., May 1, 2008; 135(5): 991 - 998.e2.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Gourine, S. I. Bondar, K. M. Spyer, and A. V. Gourine
Beneficial Effect of the Central Nervous System {beta}-Adrenoceptor Blockade on the Failing Heart
Circ. Res., March 28, 2008; 102(6): 633 - 636.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
E. F. Lewis, E. J. Velazquez, S. D. Solomon, A. S. Hellkamp, J. J.V. McMurray, J. Mathias, J.-L. Rouleau, A. P. Maggioni, K. Swedberg, L. Kober, et al.
Predictors of the first heart failure hospitalization in patients who are stable survivors of myocardial infarction complicated by pulmonary congestion and/or left ventricular dysfunction: a VALIANT study
Eur. Heart J., March 2, 2008; 29(6): 748 - 756.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. C. Chachques, J. C. Trainini, N. Lago, M. Cortes-Morichetti, O. Schussler, and A. Carpentier
Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM Trial): Clinical Feasibility Study
Ann. Thorac. Surg., March 1, 2008; 85(3): 901 - 908.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T.-M. Lee, M.-S. Lin, and N.-C. Chang
Physiological Concentration of 17{beta}-Estradiol on Sympathetic Reinnervation in Ovariectomized Infarcted Rats
Endocrinology, March 1, 2008; 149(3): 1205 - 1213.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. N. Salloum, A. Abbate, A. Das, J.-E. Houser, C. A. Mudrick, I. Z. Qureshi, N. N. Hoke, S. K. Roy, W. R. Brown, S. Prabhakar, et al.
Sildenafil (Viagra) attenuates ischemic cardiomyopathy and improves left ventricular function in mice
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1398 - H1406.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Nahrendorf, E. Aikawa, J.-L. Figueiredo, L. Stangenberg, S. W. van den Borne, W. M. Blankesteijn, D. E. Sosnovik, F. A. Jaffer, C.-H. Tung, and R. Weissleder
Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: implications for FXIII therapy and antithrombin use in myocardial infarction
Eur. Heart J., February 2, 2008; 29(4): 445 - 454.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. Sato, M. Hiroe, T. Nozato, H. Hikita, Y. Ito, H. Ohigashi, M. Tamura, A. Takahashi, M. Isobe, and K. Aonuma
Early validation study of 64-slice multidetector computed tomography for the assessment of myocardial viability and the prediction of left ventricular remodelling after acute myocardial infarction
Eur. Heart J., February 2, 2008; 29(4): 490 - 498.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. Fukui, S. Kitagawa-Sakakida, S. Kawamata, G. Matsumiya, N. Kawaguchi, N. Matsuura, and Y. Sawa
Therapeutic Effect of Midkine on Cardiac Remodeling in Infarcted Rat Hearts
Ann. Thorac. Surg., February 1, 2008; 85(2): 562 - 570.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. Timmers, J. P.G. Sluijter, J. K. van Keulen, I. E. Hoefer, M. G.J. Nederhoff, M.-J. Goumans, P. A. Doevendans, C. J.A. van Echteld, J. A. Joles, P. H. Quax, et al.
Toll-Like Receptor 4 Mediates Maladaptive Left Ventricular Remodeling and Impairs Cardiac Function After Myocardial Infarction
Circ. Res., February 1, 2008; 102(2): 257 - 264.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Beeri, C. Yosefy, J. L. Guerrero, F. Nesta, S. Abedat, M. Chaput, F. del Monte, M. D. Handschumacher, R. Stroud, S. Sullivan, et al.
Mitral regurgitation augments post-myocardial infarction remodeling failure of hypertrophic compensation.
J. Am. Coll. Cardiol., January 29, 2008; 51(4): 476 - 486.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
A. K. Agnihotri, J. C. Madsen, and W. M. Daggett Jr
Surgical Treatment of Complications of Acute Myocardial Infarction: Postinfarction Ventricular Septal Defect and Free Wall Rupture
Card. Surg. Adult, January 1, 2008; 3(2008): 753 - 784.
[Full Text]


Home page
Card Surg AdultHome page
W. Y. Szeto, R. C. Gorman, J. H. Gorman III, and M. A. Acker
Ischemic Mitral Regurgitation
Card. Surg. Adult, January 1, 2008; 3(2008): 785 - 802.
[Full Text]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T.-M. Lee, M.-S. Lin, and N.-C. Chang
Effect of pravastatin on sympathetic reinnervation in postinfarcted rats
Am J Physiol Heart Circ Physiol, December 1, 2007; 293(6): H3617 - H3626.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. Nahrendorf, F. K. Swirski, E. Aikawa, L. Stangenberg, T. Wurdinger, J.-L. Figueiredo, P. Libby, R. Weissleder, and M. J. Pittet
The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions
J. Exp. Med., November 26, 2007; 204(12): 3037 - 3047.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Bujak, G. Ren, H. J. Kweon, M. Dobaczewski, A. Reddy, G. Taffet, X.-F. Wang, and N. G. Frangogiannis
Essential Role of Smad3 in Infarct Healing and in the Pathogenesis of Cardiac Remodeling
Circulation, November 6, 2007; 116(19): 2127 - 2138.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
L. Galiuto, S. Barchetta, S. Paladini, G. Lanza, A. G Rebuzzi, M. Marzilli, and F. Crea
Functional and structural correlates of persistent ST elevation after acute myocardial infarction successfully treated by percutaneous coronary intervention
Heart, November 1, 2007; 93(11): 1376 - 1380.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. A.I. Virag, M. L. Rolle, J. Reece, S. Hardouin, E. O. Feigl, and C. E. Murry
Fibroblast Growth Factor-2 Regulates Myocardial Infarct Repair: Effects on Cell Proliferation, Scar Contraction, and Ventricular Function
Am. J. Pathol., November 1, 2007; 171(5): 1431 - 1440.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
S. Sirivella and I. Gielchinsky
Results of Coronary Bypass and Valve Operations for Mitral Valve Regurgitation
Asian Cardiovasc Thorac Ann, October 1, 2007; 15(5): 396 - 404.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. G. Spinale
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
Physiol Rev, October 1, 2007; 87(4): 1285 - 1342.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Uemura, M. Li, T. Tsutsumi, T. Yamazaki, T. Kawada, A. Kamiya, M. Inagaki, K. Sunagawa, and M. Sugimachi
Efferent vagal nerve stimulation induces tissue inhibitor of metalloproteinase-1 in myocardial ischemia-reperfusion injury in rabbit
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2254 - H2261.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Severino, M. Campioni, S. Straino, F. N. Salloum, N. Schmidt, U. Herbrand, S. Frede, G. Toietta, G. Di Rocco, R. Bussani, et al.
Identification of Protein Disulfide Isomerase as a Cardiomyocyte Survival Factor in Ischemic Cardiomyopathy
J. Am. Coll. Cardiol., September 11, 2007; 50(11): 1029 - 1037.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. Beeri, C. Yosefy, J. L. Guerrero, S. Abedat, M. D. Handschumacher, R. E. Stroud, S. Sullivan, M. Chaput, D. Gilon, G. J. Vlahakes, et al.
Early Repair of Moderate Ischemic Mitral Regurgitation Reverses Left Ventricular Remodeling: A Functional and Molecular Study
Circulation, September 11, 2007; 116(11_suppl): I-288 - I-293.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. C. Shuros, R. W. Salo, V. G. Florea, J. Pastore, M. A. Kuskowski, Y. Chandrashekhar, and I. S. Anand
Ventricular Preexcitation Modulates Strain and Attenuates Cardiac Remodeling in a Swine Model of Myocardial Infarction
Circulation, September 4, 2007; 116(10): 1162 - 1169.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
D. Chen, R. Chang, B. Umakanthan, L. N. Stoletniy, and J. T. Heywood
Improvement of Cardiac Function Persists Long Term With Medical Therapy for Left Ventricular Systolic Dysfunction
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2007; 12(3): 220 - 226.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. P. Chandler, E. E. Morgan, T. A. McElfresh, T. A. Kung, J. H. Rennison, B. D. Hoit, and M. E. Young
Heart failure progression is accelerated following myocardial infarction in type 2 diabetic rats
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1609 - H1616.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. Gomez, H. Thibault, A. Gharib, J.-M. Dumont, G. Vuagniaux, P. Scalfaro, G. Derumeaux, and M. Ovize
Inhibition of mitochondrial permeability transition improves functional recovery and reduces mortality following acute myocardial infarction in mice
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1654 - H1661.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. T. Colston, S. D. de la Rosa, M. Koehler, K. Gonzales, R. Mestril, G. L. Freeman, S. R. Bailey, and B. Chandrasekar
Wnt-induced secreted protein-1 is a prohypertrophic and profibrotic growth factor
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1839 - H1846.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T.-M. Lee, M.-S. Lin, and N.-C. Chang
Inhibition of histone deacetylase on ventricular remodeling in infarcted rats
Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H968 - H977.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Erbs, A. Linke, V. Schachinger, B. Assmus, H. Thiele, K.-W. Diederich, C. Hoffmann, S. Dimmeler, T. Tonn, R. Hambrecht, et al.
Restoration of Microvascular Function in the Infarct-Related Artery by Intracoronary Transplantation of Bone Marrow Progenitor Cells in Patients With Acute Myocardial Infarction: The Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) Trial
Circulation, July 24, 2007; 116(4): 366 - 374.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. Cheung, D. A. Bluemke, R. Klein, A. R. Sharrett, F.M. A. Islam, M. F. Cotch, B. E.K. Klein, M. H. Criqui, and T. Y. Wong
Retinal Arteriolar Narrowing and Left Ventricular Remodeling: The Multi-Ethnic Study of Atherosclerosis
J. Am. Coll. Cardiol., July 3, 2007; 50(1): 48 - 55.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Thibault, L. Gomez, E. Donal, G. Pontier, M. Scherrer-Crosbie, M. Ovize, and G. Derumeaux
Acute myocardial infarction in mice: assessment of transmurality by strain rate imaging
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H496 - H502.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. E. Udelson, F. A. McGrew, E. Flores, H. Ibrahim, S. Katz, G. Koshkarian, T. O'Brien, M. W. Kronenberg, C. Zimmer, C. Orlandi, et al.
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study on the Effect of Oral Tolvaptan on Left Ventricular Dilation and Function in Patients With Heart Failure and Systolic Dysfunction
J. Am. Coll. Cardiol., June 5, 2007; 49(22): 2151 - 2159.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
S. Gizurarson, M. Lorentzon, T. Ramunddal, F. Waagstein, L. Bergfeldt, and E. Omerovic
Effects of complete heart block on myocardial function, morphology, and energy metabolism in the rat
Europace, June 1, 2007; 9(6): 411 - 416.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
A. Abdel-Latif, R. Bolli, I. M. Tleyjeh, V. M. Montori, E. C. Perin, C. A. Hornung, E. K. Zuba-Surma, M. Al-Mallah, and B. Dawn
Adult Bone Marrow-Derived Cells for Cardiac Repair: A Systematic Review and Meta-analysis
Arch Intern Med, May 28, 2007; 167(10): 989 - 997.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
U. Sartipy, A. Albage, P. T. Larsson, P. Insulander, and D. Lindblom
Changes in B-type natriuretic peptides after surgical ventricular restoration
Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 922 - 928.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
F. Fernandez-Aviles, J. J. Alonso, G. Pena, J. Blanco, J. Alonso-Briales, J. Lopez-Mesa, F. Fernandez-Vazquez, J. Moreu, R. A. Hernandez, A. Castro-Beiras, et al.
Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial
Eur. Heart J., April 2, 2007; 28(8): 949 - 960.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Doerries, K. Grote, D. Hilfiker-Kleiner, M. Luchtefeld, A. Schaefer, S. M. Holland, S. Sorrentino, C. Manes, B. Schieffer, H. Drexler, et al.
Critical Role of the NAD(P)H Oxidase Subunit p47phox for Left Ventricular Remodeling/Dysfunction and Survival After Myocardial Infarction
Circ. Res., March 30, 2007; 100(6): 894 - 903.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
V. G. Florea
Classifying Systolic and Diastolic Heart Failure
JAMA, March 14, 2007; 297(10): 1058 - 1059.
[Full Text] [PDF]


Home page
CirculationHome page
L. Timmers, J. P.G. Sluijter, C. W.J. Verlaan, P. Steendijk, M. J. Cramer, M. Emons, C. Strijder, P. F. Grundeman, S. K. Sze, L. Hua, et al.
Cyclooxygenase-2 Inhibition Increases Mortality, Enhances Left Ventricular Remodeling, and Impairs Systolic Function After Myocardial Infarction in the Pig
Circulation, January 23, 2007; 115(3): 326 - 332.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
L. C. Amado, K. H. Schuleri, A. P. Saliaris, A. J. Boyle, R. Helm, B. Oskouei, M. Centola, V. Eneboe, R. Young, J. A.C. Lima, et al.
Multimodality Noninvasive Imaging Demonstrates In Vivo Cardiac Regeneration After Mesenchymal Stem Cell Therapy
J. Am. Coll. Cardiol., November 21, 2006; 48(10): 2116 - 2124.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
E. J. Birks, P. D. Tansley, J. Hardy, R. S. George, C. T. Bowles, M. Burke, N. R. Banner, A. Khaghani, and M. H. Yacoub
Left Ventricular Assist Device and Drug Therapy for the Reversal of Heart Failure
N. Engl. J. Med., November 2, 2006; 355(18): 1873 - 1884.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Mukherjee, J. T. Mingoia, J. A. Bruce, J. S. Austin, R. E. Stroud, G. P. Escobar, D. M. McClister Jr, C. M. Allen, M. A. Alfonso-Jaume, M. E. Fini, et al.
Selective spatiotemporal induction of matrix metalloproteinase-2 and matrix metalloproteinase-9 transcription after myocardial infarction
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2216 - H2228.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
F. B. Engel, P. C. H. Hsieh, R. T. Lee, and M. T. Keating
FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction
PNAS, October 17, 2006; 103(42): 15546 - 15551.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. Curcio, T. Noma, S. V. Naga Prasad, M. J. Wolf, A. Lemaire, C. Perrino, L. Mao, and H. A. Rockman
Competitive displacement of phosphoinositide 3-kinase from beta-adrenergic receptor kinase-1 improves postinfarction adverse myocardial remodeling
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1754 - H1760.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T.-M. Lee, M.-S. Lin, T.-F. Chou, and N.-C. Chang
Additive effects of combined blockade of AT1 receptor and HMG-CoA reductase on left ventricular remodeling in infarcted rats
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1281 - H1289.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Kawano, T. Kubota, Y. Monden, T. Tsutsumi, T. Inoue, N. Kawamura, H. Tsutsui, and K. Sunagawa
Blockade of NF-{kappa}B improves cardiac function and survival after myocardial infarction
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H1337 - H1344.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Y. Li, G. Takemura, H. Okada, S. Miyata, R. Maruyama, L. Li, M. Higuchi, S. Minatoguchi, T. Fujiwara, and H. Fujiwara
Reduction of inflammatory cytokine expression and oxidative damage by erythropoietin in chronic heart failure
Cardiovasc Res, September 1, 2006; 71(4): 684 - 694.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Tada, Y. Kagaya, M. Takeda, J. Ohta, Y. Asaumi, K. Satoh, K. Ito, A. Karibe, K. Shirato, N. Minegishi, et al.
Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion
Cardiovasc Res, August 1, 2006; 71(3): 466 - 477.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Cheng, T. C. Nguyen, M. Malinowski, F. Langer, D. Liang, G. T. Daughters, N. B. Ingels Jr, and D. C. Miller
Passive Ventricular Constraint Prevents Transmural Shear Strain Progression in Left Ventricle Remodeling
Circulation, July 4, 2006; 114(1_suppl): I-79 - I-86.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page